Name | Recombinant Human BDH1 (N-6His) |
Purity | Greater than 95% as determined by reducing SDS-PAGE |
Endotoxin level | <1 EU/µg as determined by LAL test. |
Construction | Recombinant Human D-beta-Hydroxybutyrate Dehydrogenase Mitochondrial/BDH1 is produced by our E.coli expression system and the target gene encoding Met1-Arg343 is expressed with a 6His tag at the N-terminus. |
Accession # | Q02338 |
Host | E.coli |
Species | Human |
Predicted Molecular Mass | 40.3 KDa |
Buffer | Supplied as a 0.2 μm filtered solution of 50mM Tris-HCl, 1mM DTT, pH 7.5. |
Form | Liquid |
Shipping | The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
Stability&Storage | Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
Alternative Names
D-Beta-Hydroxybutyrate Dehydrogenase Mitochondrial; BDH; 3-Hydroxybutyrate Dehydrogenase; BDH
Background
D-Beta-Hydroxybutyrate Dehydrogenase Mitochondrial (BDH) is a member of the short-chain dehydrogenases/reductases (SDR) family. BDH is localized in the mitochondrion matrix. BDH forms a homotetrameric lipid-requiring enzyme of the mitochondrial membrane and has a specific necessity for phosphatidylcholine for optimal enzymatic activity. BDH catalyzes the interconversion of acetoacetate and (R)-3-hydroxybutyrate, the 2 main ketone bodies formed during fatty acid catabolism.
Note
For Research Use Only , Not for Diagnostic Use.